key: cord-0820960-5flrjdhg
authors: Hashimoto, Takanao; Sawano, Toyoaki; Ozaki, Akihiko; Tsubokura, Masaharu; Tsuchiya, Takashi
title: Need for more proactive use of pharmacists in the COVID-19 pandemic following lessons learnt from the Great East Japan Earthquake
date: 2020-10-26
journal: Journal of global health
DOI: 10.7189/jogh.10.020397
sha: ea44faca64f13c3bd7dd3fc7e9c04d658bfa212d
doc_id: 820960
cord_uid: 5flrjdhg

nan

notebooks to record their work because the regular functioning of medical facilities had been rendered inoperable due to the tsunami [6] , These efforts might help guide efforts in helping to cope with the COVID-19 pandemic.

Further, management of the living environment by pharmacists was also helpful during the GEJE, which could be applicable to the COVID-19 pandemic. Basically, pharmacists have controlled environmental factors in schools and other public facilities, such as temperature, humidity, water quality, dust level, and pests, in Japan [7] . For that reason, after the GEJE, pharmacists could have helped raise the awareness of evacuees to the appropriate use of disinfectants or sanitation of temporary toilets, as well as the temperature and humidity in evacuation sites. In Minamisanriku Town, Miyagi Prefecture, a municipality badly affected by the tsunami, evacuees were forced to live in narrow spaces because the main part of the evacuation center was used to store dead bodies and relief materials. Because water and sewage services were shut down for five months, the use of water other than drinking was limited to once a day. Hand sanitizer was very useful to disinfect and cleanse hands directly under the guidance of pharmacists in evacuation sites. It would be valuable during the COVID-19 pandemic for pharmacists to proactively intervene in the improvement of the living environment where infections are likely to occur.

Reflecting the GEJE, the training was started for "Pharmacy Disaster Life Support (PhDLS)" personnel who were destined to be responsible for the supply of drugs and the planning of pharmaceutical support activities in a large-scale disaster [8] . Large quantities of relief materials were haphazardly piled up at evacuation centers after the GEJE and on-site health care professionals (HCPs) were confused due to the mix of brand name drugs and generics. Pharmacists had checked the ingredients of drugs and suggested alternatives to prescriptions written by physicians based on availability. The practical role of such pharmacists is one of the most insightful and important points for future disasters preparedness.

However, it appeared that the lessons learnt in past major disasters, particularly with regard to drug or sanitary material were not applied during the COVID-19 outbreak in Japan. The role of pharmacists in the COV-ID-19 pandemic, including drug supply and pharmacotherapy planning ( Table 1) , has been gradually reported [9] . On the other hand, according to Japanese guideline regarding "temporary pharmaceutical distribution at the large-scale disaster" [6] , under the leadership of local governments, physicians, pharmacists, local pharmaceutical wholesalers and others have to work together and build systems to ensure drug delivery, with no shortages or coverage at the time of a disaster. However, supply systems had not functioned effectively during the COVID-19 outbreak, Management of living environment by pharmacist may be useful to prevent the spread of COVID-19 infection, given the experience that the sanitation management by pharmacist in evacuation centers after the GEJE. and from March to June 2020, some HCPs were forced to use the same face masks for several days and wear rain gear or other alternatives to proper Personal Protection Equipment (PPE) and as a result, operations for infection control were inadequate in some hospitals [2] . Additionally, during the COVID-19 outbreak, PhDLS [8] had not been engaged in any activities, as far as we know. Those problems must be reviewed and we HCPs and stakeholders should revisit effective measures to prevent from such inadequate responses in future.

The current COVID-19 pandemic is projected to last for several years, based on past experiences with the Spanish Flu [10] , and will require additional efforts of HCPs. In the aftermath of the GEJE, pharmacists contributed to the supply of drugs and improvement of the environment to meet the needs of patients in the affected areas [6] . The participation of pharmacists could help support the treatment for patients in the COVID-19 pandemic.

Finally, with regard to the supply of drugs and sanitary materials and management of the living environment, the table summarizes the problems encountered during the COVID-19 pandemic and the measures taken based on GEJE's experience [6] . We hope that lessons learned from the GEJE will be one of the catalysts for rethinking the role of pharmacists during the COVID-19 pandemic.

Signatories from c. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Cabinet Secretariat. COVID-19 Information and Resources

Hospital Staff Shortage after the 2011 Triple Disaster in Fukushima, Japan-An Earthquake, Tsunamis, and Nuclear Power Plant Accident: A Case of the Soso District

Longitudinal trends in U.S. shortages of sterile solutions

Responding to disaster: guidelines for pharmacy

Guidelines for Disaster Medicine for Patients With Cardiovascular Diseases (JCS 2014/JSH 2014/JCC 2014) -Digest Version

School Pharmacist/School Environmental Hygienic Activities at School Site

Chinese pharmacists' rapid response to the COVID-19 outbreak

Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future

We would like to thank Mr. Tetsuji Kitamura, Chairman of Sendai City Pharmacists Association and its Vice Chairman Mr. Masanobu Takahashi, M.S. for providing detailed information on the activities of the pharmacists during the GEJE disaster, and also thank Prof. Andy Crump for his constructive opinions.Funding: None.

Authors' contribution: TH wrote the manuscript. All authors contributed to the design of the research, contributed to revision of the text and approved submission of the final manuscript.Conflicts of interest: Dr Ozaki reports personal fees from MNES Inc., outside the submitted work. The authors completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author) and declare no further conflicts of interest.